FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2511468931> ?p ?o ?g. }

• W2511468931 endingPage "75037" @default.
• W2511468931 startingPage "75023" @default.
• W2511468931 abstract "// Yuichiro Yoshioka 1, 6 , Takehiro Suzuki 2 , Yo Matsuo 3 , Makoto Nakakido 1 , Giichiro Tsurita 4 , Cristiano Simone 5 , Toshiaki Watanabe 6 , Naoshi Dohmae 2 , Yusuke Nakamura 1 , Ryuji Hamamoto 1 1 Section of Hematology/Oncology, Department of Medicine, The University of Chicago, MC2115 Chicago, IL 60637, USA 2 Biomolecular Characterization Unit, RIKEN Center for Sustainable Resource Science, Wako, Saitama 351-0198, Japan 3 OncoTherapy Science, Inc., Takatsu-ku, Kawasaki, Kanagawa 213-0012, Japan 4 Department of Surgery, IMSUT Hospital, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan 5 Division of Medical Genetics, Department of Biomedical Science and Human Oncology (DIMO), University of Bari ‘Aldo Moro’, Bari 70124, Italy 6 Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-8654, Japan Correspondence to: Ryuji Hamamoto, email: rhamamoto@medicine.bsd.uchicago.edu Keywords: SMYD3, AKT1, lysine methylation, PH domain, human cancer Received: April 08, 2016      Accepted: August 24, 2016      Published: September 08, 2016 ABSTRACT AKT1 is a cytosolic serine/threonine kinase that is overexpressed in various types of cancer and has a central role in human tumorigenesis. Although it is known that AKT1 is post-translationally modified in various ways including phosphorylation and ubiquitination, methylation has not been reported so far. Here we demonstrate that the protein lysine methyltransferase SMYD3 methylates lysine 14 in the PH domain of AKT1 both in vitro and in vivo . Lysine 14-substituted AKT1 shows significantly lower levels of phosphorylation at threonine 308 than wild-type AKT1, and knockdown of SMYD3 as well as treatment with a SMYD3 inhibitor significantly attenuates this phosphorylation in cancer cells. Furthermore, substitution of lysine 14 diminishes the plasma membrane accumulation of AKT1, and cancer cells overexpressing lysine 14-substiuted AKT1 shows lower growth rate than those overexpressing wild-type AKT1. These results imply that SMYD3-mediated methylation of AKT1 at lysine 14 is essential for AKT1 activation and that SMYD3-mediated AKT1 methylation appears to be a good target for development of anti-cancer therapy." @default.
• W2511468931 created "2016-09-16" @default.
• W2511468931 creator A5008513060 @default.
• W2511468931 creator A5011852177 @default.
• W2511468931 creator A5019809723 @default.
• W2511468931 creator A5020310674 @default.
• W2511468931 creator A5027839397 @default.
• W2511468931 creator A5037059903 @default.
• W2511468931 creator A5048973625 @default.
• W2511468931 creator A5057282547 @default.
• W2511468931 creator A5072067649 @default.
• W2511468931 creator A5079171795 @default.
• W2511468931 date "2016-09-08" @default.
• W2511468931 modified "2023-09-30" @default.
• W2511468931 title "SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1" @default.
• W2511468931 cites W1487234933 @default.
• W2511468931 cites W1492849291 @default.
• W2511468931 cites W1547119335 @default.
• W2511468931 cites W1847375317 @default.
• W2511468931 cites W1927479387 @default.
• W2511468931 cites W1966131437 @default.
• W2511468931 cites W1966133006 @default.
• W2511468931 cites W1979064162 @default.
• W2511468931 cites W1980009033 @default.
• W2511468931 cites W1985991142 @default.
• W2511468931 cites W1988323955 @default.
• W2511468931 cites W1990378797 @default.
• W2511468931 cites W1991260580 @default.
• W2511468931 cites W1992034241 @default.
• W2511468931 cites W1996122750 @default.
• W2511468931 cites W1996315419 @default.
• W2511468931 cites W2003883485 @default.
• W2511468931 cites W2005715240 @default.
• W2511468931 cites W2005784985 @default.
• W2511468931 cites W2011360946 @default.
• W2511468931 cites W2018023891 @default.
• W2511468931 cites W2033210402 @default.
• W2511468931 cites W2036357556 @default.
• W2511468931 cites W2042302972 @default.
• W2511468931 cites W2050182646 @default.
• W2511468931 cites W2052346464 @default.
• W2511468931 cites W2054332862 @default.
• W2511468931 cites W2054337776 @default.
• W2511468931 cites W2059173918 @default.
• W2511468931 cites W2065674479 @default.
• W2511468931 cites W2070772602 @default.
• W2511468931 cites W2074310370 @default.
• W2511468931 cites W2079521830 @default.
• W2511468931 cites W2081184765 @default.
• W2511468931 cites W2090333443 @default.
• W2511468931 cites W2093045397 @default.
• W2511468931 cites W2097733751 @default.
• W2511468931 cites W2101575082 @default.
• W2511468931 cites W2101859467 @default.
• W2511468931 cites W2102769765 @default.
• W2511468931 cites W2111494715 @default.
• W2511468931 cites W2115476193 @default.
• W2511468931 cites W2119123652 @default.
• W2511468931 cites W2122814930 @default.
• W2511468931 cites W2126233883 @default.
• W2511468931 cites W2126404692 @default.
• W2511468931 cites W2140476291 @default.
• W2511468931 cites W2141108574 @default.
• W2511468931 cites W2141935659 @default.
• W2511468931 cites W2142354219 @default.
• W2511468931 cites W2145013377 @default.
• W2511468931 cites W2146634563 @default.
• W2511468931 cites W2146893734 @default.
• W2511468931 cites W2159512384 @default.
• W2511468931 cites W2167111298 @default.
• W2511468931 cites W2170950090 @default.
• W2511468931 cites W2170958348 @default.
• W2511468931 cites W2261566286 @default.
• W2511468931 cites W2325979135 @default.
• W2511468931 doi "https://doi.org/10.18632/oncotarget.11898" @default.
• W2511468931 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5342720" @default.
• W2511468931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27626683" @default.
• W2511468931 hasPublicationYear "2016" @default.
• W2511468931 type Work @default.
• W2511468931 sameAs 2511468931 @default.
• W2511468931 citedByCount "37" @default.
• W2511468931 countsByYear W25114689312016 @default.
• W2511468931 countsByYear W25114689312017 @default.
• W2511468931 countsByYear W25114689312018 @default.
• W2511468931 countsByYear W25114689312019 @default.
• W2511468931 countsByYear W25114689312020 @default.
• W2511468931 countsByYear W25114689312021 @default.
• W2511468931 countsByYear W25114689312022 @default.
• W2511468931 countsByYear W25114689312023 @default.
• W2511468931 crossrefType "journal-article" @default.
• W2511468931 hasAuthorship W2511468931A5008513060 @default.
• W2511468931 hasAuthorship W2511468931A5011852177 @default.
• W2511468931 hasAuthorship W2511468931A5019809723 @default.
• W2511468931 hasAuthorship W2511468931A5020310674 @default.
• W2511468931 hasAuthorship W2511468931A5027839397 @default.
• W2511468931 hasAuthorship W2511468931A5037059903 @default.
• W2511468931 hasAuthorship W2511468931A5048973625 @default.
• W2511468931 hasAuthorship W2511468931A5057282547 @default.

• next